4.5 Article

First evidence of SOX2 mutations in Peters' anomaly: Lessons from molecular screening of 95 patients

Journal

CLINICAL GENETICS
Volume 101, Issue 5-6, Pages 494-506

Publisher

WILEY
DOI: 10.1111/cge.14123

Keywords

anterior segment dysgenesis; B3GLCT; CNV; FOXE3; microphthalmia; PAX6; Peters' anomaly; PITX3; SOX2

Funding

  1. French National Research Agency [ANR-10-COHO-0003]
  2. Agence Nationale de la Recherche (ANR) [ANR-10-COHO-0003] Funding Source: Agence Nationale de la Recherche (ANR)

Ask authors/readers for more resources

Peters' anomaly is a rare anterior segment dysgenesis characterized by central corneal opacity and irido-lenticulo-corneal adhesions. In this study, genetic defects involving 12 genes and copy number variations were identified in a cohort of Peters' anomaly patients. B3GLCT and PAX6 were the most frequently implicated genes, and SOX2 was unexpectedly found to be associated with Peters' anomaly for the first time, providing new evidence for its role in corneal transparency and anterior segment development.
Peters' anomaly (PA) is a rare anterior segment dysgenesis characterized by central corneal opacity and irido-lenticulo-corneal adhesions. Several genes are involved in syndromic or isolated PA (B3GLCT, PAX6, PITX3, FOXE3, CYP1B1). Some copy number variations (CNVs) have also been occasionally reported. Despite this genetic heterogeneity, most of patients remain without genetic diagnosis. We retrieved a cohort of 95 individuals with PA and performed genotyping using a combination of comparative genomic hybridization, whole genome, exome and targeted sequencing of 119 genes associated with ocular development anomalies. Causative genetic defects involving 12 genes and CNVs were identified for 1/3 of patients. Unsurprisingly, B3GLCT and PAX6 were the most frequently implicated genes, respectively in syndromic and isolated PA. Unexpectedly, the third gene involved in our cohort was SOX2, the major gene of micro-anophthalmia. Four unrelated patients with PA (isolated or with microphthalmia) were carrying pathogenic variants in this gene that was never associated with PA before. Here we described the largest cohort of PA patients ever reported. The genetic bases of PA are still to be explored as genetic diagnosis was unavailable for 2/3 of patients. Nevertheless, we showed here for the first time the involvement of SOX2 in PA, offering new evidence for its role in corneal transparency and anterior segment development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available